| - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | | - | |
|
|
|
| dactinomycin |
 |
A compound composed of a two cyclic peptides attached to a phenoxazine that is derived from streptomyces parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015)
[ Articles | Books | Images | Discussion groups ]
|
|
Additional comments :
(Actinomycin, Actinomycin D, Meractinomycin, Ac-De, Cosmegen, Cosmegen Lyovac)
|
|
|
|
|